DE69219900D1 - 5-o-desosaminylerythronolid derivate - Google Patents

5-o-desosaminylerythronolid derivate

Info

Publication number
DE69219900D1
DE69219900D1 DE69219900T DE69219900T DE69219900D1 DE 69219900 D1 DE69219900 D1 DE 69219900D1 DE 69219900 T DE69219900 T DE 69219900T DE 69219900 T DE69219900 T DE 69219900T DE 69219900 D1 DE69219900 D1 DE 69219900D1
Authority
DE
Germany
Prior art keywords
moiety
optionally substituted
desosaminylerythronolide
hydrogen
derivate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69219900T
Other languages
English (en)
Other versions
DE69219900T2 (de
Inventor
Toshifumi Taisho Pharmac Asaka
Yoko Taisho Pharmaceuti Misawa
Masato Taisho Pharma Kashimura
Shigeo Taisho Pharmac Morimoto
Katsuo Taisho Pharmac Hatayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of DE69219900D1 publication Critical patent/DE69219900D1/de
Application granted granted Critical
Publication of DE69219900T2 publication Critical patent/DE69219900T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69219900T 1991-12-27 1992-12-25 5-o-desosaminylerythronolid derivate Expired - Fee Related DE69219900T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP34682691 1991-12-27
JP19936892 1992-07-27
JP27986792 1992-10-19
PCT/JP1992/001714 WO1993013116A1 (en) 1991-12-27 1992-12-25 5-o-desosaminylerythronolide derivative

Publications (2)

Publication Number Publication Date
DE69219900D1 true DE69219900D1 (de) 1997-06-26
DE69219900T2 DE69219900T2 (de) 1997-09-11

Family

ID=27327638

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69219900T Expired - Fee Related DE69219900T2 (de) 1991-12-27 1992-12-25 5-o-desosaminylerythronolid derivate
DE69217989T Expired - Fee Related DE69217989T2 (de) 1991-12-27 1992-12-25 5-0-Desosaminylerrythronolide-Derivate

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69217989T Expired - Fee Related DE69217989T2 (de) 1991-12-27 1992-12-25 5-0-Desosaminylerrythronolide-Derivate

Country Status (10)

Country Link
US (2) US5523399A (de)
EP (2) EP0619320B1 (de)
JP (2) JP3099366B2 (de)
KR (2) KR100266183B1 (de)
AT (2) ATE153341T1 (de)
AU (2) AU667334B2 (de)
CA (2) CA2126665A1 (de)
DE (2) DE69219900T2 (de)
ES (2) ES2104118T3 (de)
WO (2) WO1993013115A1 (de)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5591837A (en) * 1992-04-22 1997-01-07 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide a derivative
CA2154550A1 (en) * 1993-01-26 1994-08-04 Yoko Misawa 5-o-desosaminylerythronolide derivatives
KR970704455A (ko) * 1994-08-12 1997-09-06 우에하라 아끼라 인터류킨 5 생성 억제제(Interleukin 5 Production Inhibitor)
FR2738571B1 (fr) * 1995-09-11 1997-10-17 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-0-methyl- erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
USRE38426E1 (en) 1995-10-09 2004-02-10 Aventis Pharma S.A. 5-O-deosaminyl 6-O-methyl erythronolide A derivatives, preparation method therefor and use thereof for preparing biologically active materials
FR2739620B1 (fr) * 1995-10-09 1997-12-19 Roussel Uclaf Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
US6274715B1 (en) * 1995-11-08 2001-08-14 Abbott Laboratories Tricyclic erythromycin derivatives
US5747466A (en) * 1995-11-08 1998-05-05 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
DE69631609T2 (de) * 1995-11-08 2005-01-05 Abbott Laboratories, Abbott Park Tricyclische erythromycinderivate
AU714176B2 (en) * 1995-11-08 1999-12-23 Abbott Laboratories 3-deoxy-3-descladinose derivatives of erythromycins A and B
WO1998009978A1 (en) * 1996-09-04 1998-03-12 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
US5804565A (en) * 1996-09-24 1998-09-08 Taisho Pharmaceutical Co., Ltd. Erythromycin A derivatives
CN1238777A (zh) 1996-11-27 1999-12-15 大正制药株式会社 红霉素a衍生物
US6140479A (en) * 1997-03-24 2000-10-31 Taisho Pharmaceuticals Co., Ltd. Erythromycin a derivatives
US6169168B1 (en) 1997-10-29 2001-01-02 Taisho Pharmaceuticals Co., Ltd. Erythromycin A derivatives
JP2004514643A (ja) * 1997-10-29 2004-05-20 大正製薬株式会社 エリスロマイシンa誘導体
WO1999021867A1 (fr) * 1997-10-29 1999-05-06 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
CN1284961A (zh) * 1997-12-11 2001-02-21 北陆制药株式会社 红霉素衍生物
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AP9801420A0 (en) * 1998-01-02 1998-12-31 Pfizer Prod Inc Novel macrolides.
FR2777282B1 (fr) * 1998-04-08 2001-04-20 Hoechst Marion Roussel Inc Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
KR100710605B1 (ko) * 1999-04-16 2007-04-24 코산 바이오사이언시즈, 인코포레이티드 매크롤라이드 항감염제
JP2003500414A (ja) * 1999-05-24 2003-01-07 ファイザー・プロダクツ・インク 13−メチルエリスロマイシン誘導体
US6420535B1 (en) * 1999-06-07 2002-07-16 Abbott Laboratories 6-O-carbamate ketolide derivatives
US6946446B2 (en) 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
EP1146051A3 (de) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A-Derivate
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
WO2005012322A1 (ja) * 2003-08-05 2005-02-10 Taisho Pharmaceutical Co., Ltd. エリスロマイシンa 11,12−サイクリックカーボネートの製造方法
WO2005030227A1 (en) 2003-09-23 2005-04-07 Enanta Pharmaceuticals, Inc. 9a, 11-3C-BICYCLIC 9a-AZALIDE DERIVATIVES
EP1781679A1 (de) * 2004-07-28 2007-05-09 Ranbaxy Laboratories Limited Antibakterielle mittel
US7402568B2 (en) 2004-09-29 2008-07-22 Enanta Pharmaceuticals, Inc. Bicyclic 9a-azalide derivatives
EP2233493A1 (de) * 2004-12-21 2010-09-29 Pfizer Products Inc. Makrolide
US7271155B2 (en) 2005-01-07 2007-09-18 Enanta Pharmaceuticals, Inc. 9A, 11-2C-bicyclic 9a-azalide derivatives
DE602006004555D1 (de) 2005-01-13 2009-02-12 Glaxosmithkline Zagreb Decladinosyl-macrolide mit entzündungshemmender wirkung
US8293715B2 (en) * 2007-08-06 2012-10-23 Taisho Pharmaceutical Co., Ltd. 10a-Azalide compound crosslinked at 10a- and 12-positions
EP2188281A1 (de) * 2007-08-10 2010-05-26 Y's Therapeutics Co, Ltd. Modulation von immunreaktionen durch verabreichung von roxithromycin oder dessen derivat
US8299035B2 (en) 2008-05-15 2012-10-30 Taisho Pharmaceutucal Co., Ltd. 10a-azalide compound having 4-membered ring structure
US8143369B2 (en) 2009-06-02 2012-03-27 International Business Machines Corporation Polymers bearing pendant pentafluorophenyl ester groups, and methods of synthesis and functionalization thereof
CN101863941A (zh) * 2010-06-03 2010-10-20 武汉大学 3-氧-取代的6,11-二-氧-甲基红霉素a的衍生物
CN104961785B (zh) * 2015-06-19 2019-01-11 北京理工大学 一种新型酰内酯衍生物及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3923784A (en) * 1973-09-10 1975-12-02 Hoffmann La Roche Erythromycin a derivatives
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
GB8521402D0 (en) * 1985-08-28 1985-10-02 Beecham Group Plc Chemical compounds
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
KR880009960A (ko) * 1987-02-24 1988-10-06 데이빗 로버츠 화학적 화합물
JPH0196190A (ja) * 1987-10-07 1989-04-14 Toyo Jozo Co Ltd 6−0−アルキル−エリスロマイシンa サイクリック11,12−カーボネート
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin

Also Published As

Publication number Publication date
ATE153341T1 (de) 1997-06-15
AU3172793A (en) 1993-07-28
CA2126665A1 (en) 1993-07-08
EP0619320A4 (de) 1994-11-02
EP0619319A4 (de) 1994-11-02
JP3099366B2 (ja) 2000-10-16
ATE149508T1 (de) 1997-03-15
EP0619319A1 (de) 1994-10-12
KR100265916B1 (ko) 2000-09-15
ES2101290T3 (es) 1997-07-01
CA2126664A1 (en) 1993-07-08
AU667334B2 (en) 1996-03-21
KR940703842A (ko) 1994-12-12
JP3132002B2 (ja) 2001-02-05
WO1993013116A1 (en) 1993-07-08
DE69217989T2 (de) 1997-06-12
ES2104118T3 (es) 1997-10-01
DE69219900T2 (de) 1997-09-11
EP0619320A1 (de) 1994-10-12
US5631354A (en) 1997-05-20
KR100266183B1 (ko) 2000-09-15
AU663145B2 (en) 1995-09-28
KR940703841A (ko) 1994-12-12
DE69217989D1 (de) 1997-04-10
AU3172893A (en) 1993-07-28
US5523399A (en) 1996-06-04
WO1993013115A1 (en) 1993-07-08
EP0619319B1 (de) 1997-03-05
EP0619320B1 (de) 1997-05-21

Similar Documents

Publication Publication Date Title
DE69219900D1 (de) 5-o-desosaminylerythronolid derivate
DE69305987D1 (de) 5-0-desosaminylerythronolide a derivate
ATE157368T1 (de) 6-0-methylerythromycin a-derivat
ATE138919T1 (de) Pyranylcyanoguanidinderivate
DE69224234T2 (de) 4-a-Substutierte Avermectinderivate
FI922561A (fi) Derivat av 1-metylkarbapenem, deras frmastaellning och anvaendning som antibiotika
DE69024397D1 (de) Diaminoethylen-Verbindungen
FI814148L (fi) Nya trisubstituerade pyrimido/5,4-d/pyrimidiner deras framstaellning och deras anvaendning saosom laekemedel
ES2188481T3 (es) Derivados de polinalbufina.
TR199901301T2 (xx) Yeni eritromisin t�revleri ve bunlar�n haz�rlanma y�ntemi.
ES2096628T3 (es) Derivados heterociclicos.
GB2104515B (en) Sulphimines
DE3787986D1 (de) Macrolid-Derivate.
DE3851190D1 (de) Makrolid-Derivate.
NO920619L (no) Oxazinobenzazolforbindelser
ES2125859T3 (es) Derivados de pirazoloacridona.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee